1st Quarter - Report

BIOCOM for BIOCOM

Firm
Client
Income
—
Expenses
$45,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Provided information on industry's response regarding the covid-19 pandemic Advocated against international reference pricing policies, including most favored nation and HR3 Presented new data from Vital Transformation on the impact of HR3 Hosted a webinar on international reference pricing Hosted a roundtable with Rep. Sara Jacobs Advocated in favor of CMS's MCIT coverage pathway for devices designated as breakthrough by the FDA Advocated against CMS's rule to waive protections for protected classes of drugs

LobbyistCovered position, as disclosed
LAURE FABREGA CLARK —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 3 (117th)

Copyright/Patent/Trademark CPT

Expressed importance of intellectual property protections for the life science industry

LobbyistCovered position, as disclosed
LAURE FABREGA CLARK —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.